414 related articles for article (PubMed ID: 19663687)
21. Post-neonatal hospitalization and health care costs among IVF children: a 7-year follow-up study.
Koivurova S; Hartikainen AL; Gissler M; Hemminki E; Järvelin MR
Hum Reprod; 2007 Aug; 22(8):2136-41. PubMed ID: 17584752
[TBL] [Abstract][Full Text] [Related]
22. The cost of systemic sclerosis.
Bernatsky S; Hudson M; Panopalis P; Clarke AE; Pope J; Leclercq S; St Pierre Y; Baron M;
Arthritis Rheum; 2009 Jan; 61(1):119-23. PubMed ID: 19116974
[TBL] [Abstract][Full Text] [Related]
23. The economic effect of oral linezolid versus intravenous vancomycin in the outpatient setting: the payer perspective.
McKinnon PS; Carter CT; Girase PG; Liu LZ; Carmeli Y
Manag Care Interface; 2007 Jan; 20(1):23-34. PubMed ID: 17310650
[TBL] [Abstract][Full Text] [Related]
24. Asthma costs and utilization in a managed care organization.
Zeiger RS; Hay JW; Contreras R; Chen W; Quinn VP; Seal B; Schatz M
J Allergy Clin Immunol; 2008 Apr; 121(4):885-92.e5. PubMed ID: 18313133
[TBL] [Abstract][Full Text] [Related]
25. Day hospital vs. home treatment--a comparison of illness severity and costs.
Harrison J; Marshall S; Marshall P; Marshall J; Creed F
Soc Psychiatry Psychiatr Epidemiol; 2003 Oct; 38(10):541-6. PubMed ID: 14564381
[TBL] [Abstract][Full Text] [Related]
26. Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients.
Delong LK; Culler SD; Saini SS; Beck LA; Chen SC
Arch Dermatol; 2008 Jan; 144(1):35-9. PubMed ID: 18209166
[TBL] [Abstract][Full Text] [Related]
27. Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain.
Boulanger L; Zhao Y; Foster TS; Fraser K; Bledsoe SL; Russell MW
Curr Med Res Opin; 2009 Jul; 25(7):1763-73. PubMed ID: 19505204
[TBL] [Abstract][Full Text] [Related]
28. Applying diagnostic cost groups to examine the disease burden of VA facilities: comparing the six "Evaluating VA Costs" study sites with other VA sites and Medicare.
Rosen AK; Loveland S; Anderson JJ
Med Care; 2003 Jun; 41(6 Suppl):II91-102. PubMed ID: 12773831
[TBL] [Abstract][Full Text] [Related]
29. Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence.
Balu S; Simko RJ; Quimbo RM; Cziraky MJ
Curr Med Res Opin; 2009 Nov; 25(11):2765-75. PubMed ID: 19785511
[TBL] [Abstract][Full Text] [Related]
30. Association of patient-reported psoriasis severity with income and employment.
Horn EJ; Fox KM; Patel V; Chiou CF; Dann F; Lebwohl M
J Am Acad Dermatol; 2007 Dec; 57(6):963-71. PubMed ID: 17761358
[TBL] [Abstract][Full Text] [Related]
31. Economic burden of osteoporosis, breast cancer, and cardiovascular disease among postmenopausal women in an employed population.
Sasser AC; Rousculp MD; Birnbaum HG; Oster EF; Lufkin E; Mallet D
Womens Health Issues; 2005; 15(3):97-108. PubMed ID: 15894195
[TBL] [Abstract][Full Text] [Related]
32. Economic burden prior to COPD diagnosis: a matched case-control study in the United States.
Akazawa M; Halpern R; Riedel AA; Stanford RH; Dalal A; Blanchette CM
Respir Med; 2008 Dec; 102(12):1744-52. PubMed ID: 18760581
[TBL] [Abstract][Full Text] [Related]
33. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
Halpern R; Mody RR; Fuldeore MJ; Patel PA; Mikuls TR
Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724
[TBL] [Abstract][Full Text] [Related]
34. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
Munakata J; Hazard E; Serrano D; Klingman D; Rupnow MF; Tierce J; Reed M; Lipton RB
Headache; 2009 Apr; 49(4):498-508. PubMed ID: 19245386
[TBL] [Abstract][Full Text] [Related]
35. Does the severity of mood and anxiety symptoms predict health care utilization?
Nease DE; Volk RJ; Cass AR
J Fam Pract; 1999 Oct; 48(10):769-77. PubMed ID: 12224674
[TBL] [Abstract][Full Text] [Related]
36. Health care resource use, productivity, and costs among patients with moderate to severe plaque psoriasis in the United States.
Schaefer CP; Cappelleri JC; Cheng R; Cole JC; Guenthner S; Fowler J; Johnson S; Mamolo C
J Am Acad Dermatol; 2015 Oct; 73(4):585-593.e3. PubMed ID: 26253364
[TBL] [Abstract][Full Text] [Related]
37. Costs of asthma in Italy: results of the SIRIO (Social Impact of Respiratory Integrated Outcomes) study.
Dal Negro RW; Micheletto C; Tosatto R; Dionisi M; Turco P; Donner CF
Respir Med; 2007 Dec; 101(12):2511-9. PubMed ID: 17822890
[TBL] [Abstract][Full Text] [Related]
38. Relationship between disease severity, quality of life and health-care resource use in a cross-section of Australian patients with Crohn's disease.
Gibson PR; Weston AR; Shann A; Florin TH; Lawrance IC; Macrae FA; Radford-Smith G
J Gastroenterol Hepatol; 2007 Aug; 22(8):1306-12. PubMed ID: 17559375
[TBL] [Abstract][Full Text] [Related]
39. Knee-attributable medical costs and risk of re-surgery among patients utilizing non-surgical treatment options for knee arthrofibrosis in a managed care population.
Stephenson JJ; Quimbo RA; Gu T
Curr Med Res Opin; 2010 May; 26(5):1109-18. PubMed ID: 20225995
[TBL] [Abstract][Full Text] [Related]
40. Assessing the economic burden of breast cancer in a US managed care population.
Barron JJ; Quimbo R; Nikam PT; Amonkar MM
Breast Cancer Res Treat; 2008 May; 109(2):367-77. PubMed ID: 17674201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
